default author photo

Anthony Turpin

University of Lille - CHU Lille

SCHOLARLY PAPERS

3

DOWNLOADS

107

TOTAL CITATIONS

0

Scholarly Papers (3)

1.

Pemigatinib-associated toxicity and its management: implications on prognosis in patients with cholangiocarcinoma treated within real-world Italian PEMIREAL and French PEMIBIL cohorts

Number of pages: 20 Posted: 17 Dec 2025
affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Centre Hospitalier Universitaire de Toulouse, affiliation not provided to SSRN, Gustave Roussy - Drug Development Department (DITEP), University of Bordeaux - Hôpital Haut-Lévêque, affiliation not provided to SSRN, University of Montpellier - Institut régional du Cancer de Montpellier, Centre Paul Strauss, University of Claude Bernard Lyon 1 - Centre Léon Bérard, Fondazione IRCCS Istituto Nazionale dei Tumori, University of Pisa, University of Perugia, affiliation not provided to SSRN, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Academic Hospital of Udine ASUFC - Department of Oncology, Université de Poitiers - Gastroenterology Department, affiliation not provided to SSRN, affiliation not provided to SSRN, Università Vita-Salute San Raffaele - IRCCS San Raffaele Scientific Institute, Università Vita-Salute San Raffaele - IRCCS Ospedale San Raffaele, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Milano-Bicocca - Fondazione IRCCS San Gerardo dei Tintori, affiliation not provided to SSRN, affiliation not provided to SSRN, Centre Antoine Lacassagne, affiliation not provided to SSRN, University of Lille - CHU Lille, Institut de Cancérologie de l'Ouest - Department of Medical Oncology, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Institut Mutualiste Montsouris, École Normale Supérieure - PSL Research University - Institut Curie, Centre Eugène Marquis - Medical Oncology, Université de Rennes 1 - CHU de Rennes, University of Toulouse - Hospital Rangueil, IRCCS Humanitas Research Hospital, affiliation not provided to SSRN, Centre Hospitalier Universitaire de Toulouse and affiliation not provided to SSRN
Downloads 52 (1,041,696)

Abstract:

Loading...

Drug toxicity, adverse events, Cholangiocarcinoma, biliary tract cancer, FGFR2 fusions/rearrangements, Real-world Evidence, Systemic treatment, targeted therapy

2.

Perceptions of the Environmental Impact of Oncology Care: A Cross-Sectional Survey of French and Belgian Healthcare Professionals

Number of pages: 15 Posted: 13 Jan 2026
Paul Matte, Pierre-Florent Petit, Anthony Turpin and See PDF
Institut Curie, Helora University Hospitals - CHU Helora, University of Lille - CHU Lille and Please see PDF for full list of authors & affiliations
Downloads 28 (1,345,526)

Abstract:

Loading...

Oncology, Environmental impact, Greenhouse gas emissions, Sustainable healthcare, Healthcare professionals' perceptions

3.

Efficacy of targeted therapies for metastatic small bowel adenocarcinoma treatment: a retrospective study by AGEO

Number of pages: 23 Posted: 21 Jan 2026
affiliation not provided to SSRN, Gustave Roussy, Université de Poitiers - Gastroenterology Department, University of Besançon - University Hospital Besançon, affiliation not provided to SSRN, CHRU Tours, Université Paris Cité, Bergonié Institute, affiliation not provided to SSRN, Université Paris VI Pierre et Marie Curie - Hôpital Saint-Antoine, affiliation not provided to SSRN, Centre Hospitalier Universitaire de Toulouse, affiliation not provided to SSRN, Assistance Publique-Hôpitaux de Paris - Hôpital Cochin, Assistance Publique-Hopitaux de Paris (AP-HP) - Hôpital Européen Georges Pompidou, Centre Eugène Marquis - Medical Oncology, affiliation not provided to SSRN, Groupe Hospitalier Diaconesses-Croix St-Simon, affiliation not provided to SSRN and University of Lille - CHU Lille
Downloads 27 (1,359,097)

Abstract:

Loading...

Small bowel adenocarcinoma, metastasis, targeted therapies, chemotherapy